Tussamag (Tussamag)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceThyme ordinary herb extractThyme ordinary herb extract
Similar drugsTo uncover
  • Bronchicum® C
    syrup inwards 
    A. Nattermann and Sie. GmbH     Germany
  • Bronchicum® C
    lozenges inwards locally 
    A. Nattermann and Sie. GmbH     Germany
  • Bronhoplant®
    syrup inwards 
    EVALAR, CJSC     Russia
  • Pertussin
    syrup inwards 
    FITO-BOT, LLC     Russia
  • Tussamag
    syrup inwards 
    Teva Pharmaceutical Enterprises Co., Ltd.     Israel
  • Tussamag
    syrup inwards 
    ratiofarm GmbH     Germany
  • Tussamag
    drops inwards 
    ratiofarm GmbH     Germany
    • Dosage form: & nbspsyrup
    Composition:
    100 g of syrup contain:
    active substance: thyme herb extract liquid alcohol 9.0 g;
    auxiliary substances: potassium sorbate 0.10 g, citric acid monohydrate 0.086 g, dye cerestar caramel (E150d) 0.20 g, glycerol 85% 20.00 g, sorbitol 45.00 g, purified water 25.62 g.

    Description:transparent brown solution with a characteristic smell of thyme.
    Pharmacotherapeutic group:expectorant
    ATX: & nbsp

    R.05.C.A   Expectorants

    Pharmacodynamics:
    The drug Tussamag has an expectorant effect, dilutes sputum and reduces its viscosity.
    The active ingredients of the drug - thymol and carvacrol - also exert an antimicrobial effect.

    Indications:
    In the complex therapy of infectious-inflammatory diseases of the respiratory tract, accompanied by a cough with hard-to-separate sputum (including bronchitis, tracheitis, tracheobronchitis, whooping cough).

    Contraindications:
    Hypersensitivity to the components of the drug;
    heart rate decompensation;
    gastritis;
    peptic ulcer of the stomach and duodenum in the stage of exacerbation;
    hereditary intolerance to fructose;
    deficiency of sugar / isomaltazy;
    glucose galactose malabsorption;
    children under 1 year.

    Carefully:
    Diseases of the liver; alcoholism; craniocerebral trauma; diseases of the brain; children's age from 1 year.

    Pregnancy and lactation:
    There have been insufficient studies on the use of Tussamag during pregnancy and during breastfeeding. Due to this, and because of the content of ethanol in its composition, the drug should not be taken during pregnancy and during breastfeeding.

    Dosing and Administration:
    Inside, regardless of food intake.
    If the doctor has not prescribed a different dosage, the drug is taken:
    Adults and children over 12 years: 2-3 teaspoons of syrup 3-4 times a day;
    Children from 4 to 12 years: 1-2 teaspoons of syrup 3-4 times a day;
    Children from 1 year to 4 years: 1 teaspoon 2-3 times a day.
    The syrup can be taken without diluting or mixing with other liquids (for example, tea or fruit juice).

    Side effects:
    To date, no side effects have been reported with the use of the drug, but allergic reactions may occur.
    Due to the content of sorbitol in its composition, taking the drug may cause gastric
    disorders and diarrhea.

    Overdose:
    When the drug is used in doses exceeding the recommended dose, irritation of the gastrointestinal tract, vomiting, diarrhea is possible.
    Treatment is symptomatic.

    Interaction:
    Tussamag should not be used concomitantly with drugs containing codeine and other antitussive medicines, as this makes it difficult to cough up thinned phlegm.

    Special instructions:
    Due to the ethanol content, children under 12 should take Tussamag on recommendation and under the supervision of a doctor.
    The average content of ethanol taken with the Tussamag preparation at a certain dose for children from 1 year to 4 years is equivalent to 0.08 g.
    100 g of Tussamag contains 31.5 g of sorbitol. If the drug is taken in the right dose, each dose (4-6 ml of syrup) contains 1.85 g of sorbitol, which is equivalent to 0.15 bread units.

    Effect on the ability to drive transp. cf. and fur:
    When using Tussamag, care should be taken when performing actions requiring increased concentration of attention and speed of psychomotor reactions.

    Form release / dosage:
    Syrup 9%.
    For 175 g of the drug in a bottle of dark glass, ukuporenny plastic screw cap. 1 bottle with instructions for use in a cardboard box.

    Packaging:

    For 175 g of the drug in a bottle of dark glass, ukuporenny plastic screw cap. 1 bottle with instructions for use in a cardboard box.

    Storage conditions:
    At a temperature of no higher than 25 ° C.
    Keep out of the reach of children!

    Shelf life:
    3 years. After opening the bottle the drug is suitable for use for 1 year.
    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N014420 / 01
    Date of registration:18.06.2009
    The owner of the registration certificate:Teva Pharmaceutical Enterprises Co., Ltd.Teva Pharmaceutical Enterprises Co., Ltd. Israel
    Manufacturer: & nbsp
    Information update date: & nbsp02.09.2015
    Illustrated instructions
      Instructions
      Up